SCHEMBL4856397

SCHEMBL4856397

Cc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2cccc(CN(C)C)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.47
BCHE P06276 3/20 0.42
ACHE P22303 3/20 0.42
HTR7 P34969 2/20 0.40
HRH1 P35367 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR1 P03372 1/20 0.39
MAOB P27338 1/20 0.38
TNFRSF1A P19438 1/20 0.38
CYSLTR2 Q9NS75 1/20 0.38
CYSLTR1 Q9Y271 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854959 1.00 SLC6A9 (0.47) SLC6A9BCHEACHEHTR7HRH1
SCHEMBL4851256 0.91 SLC6A9 (0.46) SLC6A9BCHEACHEHRH1KDM4E
SCHEMBL4856617 0.91 SLC6A9 (0.46) SLC6A9BCHEACHEHRH1KDM4E
SCHEMBL4853880 0.89 BCHE (0.47) SLC6A9BCHEACHEHRH1KDM4E
SCHEMBL4857311 0.89 BCHE (0.47) SLC6A9BCHEACHEHRH1KDM4E
SCHEMBL4846158 0.87 BCHE (0.41) SLC6A9BCHEACHEHRH1ESR1
SCHEMBL4854696 0.87 BCHE (0.41) SLC6A9BCHEACHEHRH1ESR1
SCHEMBL4857422 0.87 BCHE (0.49) SLC6A9BCHEACHEKDM4ESMN1; SMN2
SCHEMBL4849675 0.87 SLC6A9 (0.44) SLC6A9BCHEACHEMAOBTUBB4A
SCHEMBL4852790 0.87 BCHE (0.49) SLC6A9BCHEACHEKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed